SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 72 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $252,000 | +1.6% | 459,717 | 0.0% | 0.00% | – |
| Q1 2016 | $248,000 | -40.0% | 459,717 | 0.0% | 0.00% | – |
| Q4 2015 | $413,000 | +35.4% | 459,717 | +21.9% | 0.00% | – |
| Q3 2015 | $305,000 | +362.1% | 376,983 | +1623.4% | 0.00% | – |
| Q2 2015 | $66,000 | -94.7% | 21,874 | -95.7% | 0.00% | – |
| Q1 2015 | $1,240,000 | +6.5% | 506,043 | +10.9% | 0.00% | – |
| Q4 2014 | $1,164,000 | -65.6% | 456,319 | -3.7% | 0.00% | -100.0% |
| Q3 2014 | $3,382,000 | -4.8% | 473,705 | -13.0% | 0.00% | 0.0% |
| Q2 2014 | $3,551,000 | +27.3% | 544,650 | +29.1% | 0.00% | – |
| Q1 2014 | $2,789,000 | +71.2% | 421,870 | +22.8% | 0.00% | – |
| Q4 2013 | $1,629,000 | -14.0% | 343,679 | -10.0% | 0.00% | – |
| Q3 2013 | $1,894,000 | -18.9% | 381,824 | -15.2% | 0.00% | – |
| Q2 2013 | $2,334,000 | – | 450,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,869,261 | $32,186,000 | 2.31% |
| GREAT POINT PARTNERS LLC | 193,567 | $1,279,000 | 0.67% |
| Visium Asset Management, LP | 4,526,750 | $29,922,000 | 0.48% |
| Healthcare Value Capital, LLC | 103,185 | $682,000 | 0.45% |
| ALYDAR PARTNERS LLC | 550,565 | $3,639,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 147,403 | $974,000 | 0.29% |
| HealthCor Management, L.P. | 690,000 | $4,561,000 | 0.27% |
| Sivik Global Healthcare LLC | 63,087 | $417,000 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,379,278 | $9,117,000 | 0.22% |
| Healthcare Value Capital, LLC | 50,000 | $331,000 | 0.22% |